Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.00
-0.04-1.96%
At close: Sep 11, 5:00 PM EST
$2.05
0.052.5%
After Hours: Sep 11, 9:02 AM EST
Acrivon Therapeutics Inc (ACRV) Stock Price, Quote, News & History
ACRVNASDAQ
Acrivon Therapeutics (ACRV) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acrivon Therapeutics (ACRV) stock?
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Who are Acrivon Therapeutics (ACRV) competitors?
Other companies in Acrivon Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?
Acrivon Therapeutics has a consensus price target of $18.44.
What is the current price for Acrivon Therapeutics (ACRV)?
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $2.05 last updated September 11, 2026 at 9:02 AM EDT.
Does Acrivon Therapeutics (ACRV) pay a dividend?
There are no upcoming dividends for Acrivon Therapeutics.
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics does not have any upcoming earnings scheduled.
Is Acrivon Therapeutics (ACRV) going to split?
There is no upcoming split for Acrivon Therapeutics.
What sector and industry does Acrivon Therapeutics (ACRV) operate in?
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
